US Stock MarketDetailed Quotes

NRIX Nurix Therapeutics

Watchlist
  • 19.930
  • -0.030-0.15%
Close Jan 24 16:00 ET
  • 20.000
  • +0.070+0.35%
Post 17:47 ET
1.41BMarket Cap-6.87P/E (TTM)

Nurix Therapeutics Key Stats

Nurix Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 14.777M--
--2024/Q4-- / 12.877M--
--2024/Q312.588M / 12.253M--
--2024/Q212.092M / 21.784M--
--2024/Q116.585M / 17.085M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 14.777M--
--2024/Q4-- / 12.877M--
--2024/Q312.588M / 12.253M--
--2024/Q212.092M / 21.784M--
--2024/Q116.585M / 17.085M--

Unlock Free Earnings Estimates

Nurix Therapeutics Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 24, 2025

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data